Düsseldorf, Germany

Daniele Hoffmann

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Henkel Ag & Company, Kgaa. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Daniele Hoffmann. Retrieved from https://idiyas.com/inventor/daniele-hoffmann-cqwfskab

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile



Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Daniele Hoffmann: Innovator in Deodorant Technology

Introduction

Daniele Hoffmann is a prominent inventor based in Düsseldorf, Germany. She has made significant contributions to the field of personal care products, particularly in the development of deodorants and antiperspirants. Her innovative approach focuses on addressing body odors through biochemical methods.

Latest Patents

Hoffmann holds a patent for her work on β-glucuronidase inhibitors for use in deodorants and antiperspirants. This non-therapeutic method targets the inhibition of β-glucuronidase, an enzyme responsible for the decomposition of steroid esters that leads to body odors. The patent discloses specific β-glucuronidase-inhibiting compounds that can effectively reduce unpleasant smells.

Career Highlights

Daniele Hoffmann is currently employed at Henkel Kommanditgesellschaft Auf Aktien, a leading company in the consumer goods sector. Her role involves research and development in personal care products, where she applies her expertise to create innovative solutions for everyday challenges.

Collaborations

Hoffmann collaborates with notable colleagues, including Bernhard Banowski and Armin Wadle. Together, they work on advancing the science behind personal care formulations, contributing to the company's reputation for quality and innovation.

Conclusion

Daniele Hoffmann's work exemplifies the intersection of science and consumer needs in the personal care industry. Her patent on β-glucuronidase inhibitors showcases her commitment to innovation and improving everyday products.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…